Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
957 USD
3.57%
Market Closed
Updated:
May 4, 2024
Income Statement
Earnings Waterfall
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
|
Revenue
|
13.1B
USD
|
|
Cost of Revenue
|
-1.8B
USD
|
|
Gross Profit
|
11.3B
USD
|
|
Operating Expenses
|
-7.1B
USD
|
|
Operating Income
|
4.2B
USD
|
|
Other Expenses
|
-279.6m
USD
|
|
Net Income
|
4B
USD
|
Income Statement
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Currency: USD
| Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
2 105
N/A
|
2 291
+9%
|
2 499
+9%
|
2 628
+5%
|
2 820
+7%
|
3 063
+9%
|
3 396
+11%
|
3 808
+12%
|
4 104
+8%
|
4 435
+8%
|
4 649
+5%
|
4 732
+2%
|
4 860
+3%
|
4 979
+2%
|
5 236
+5%
|
5 517
+5%
|
5 872
+6%
|
6 065
+3%
|
6 203
+2%
|
6 365
+3%
|
6 711
+5%
|
6 572
-2%
|
6 542
0%
|
6 622
+1%
|
7 863
+19%
|
7 319
-7%
|
7 693
+5%
|
8 244
+7%
|
8 497
+3%
|
9 198
+8%
|
12 384
+35%
|
13 543
+9%
|
16 072
+19%
|
16 508
+3%
|
14 227
-14%
|
13 710
-4%
|
12 173
-11%
|
12 370
+2%
|
12 671
+2%
|
13 097
+3%
|
13 117
+0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(155)
|
(170)
|
(177)
|
(194)
|
(205)
|
(246)
|
(288)
|
(341)
|
(393)
|
(421)
|
(401)
|
(336)
|
(300)
|
(272)
|
(306)
|
(366)
|
(397)
|
(428)
|
(417)
|
(423)
|
(434)
|
(491)
|
(546)
|
(661)
|
(782)
|
(813)
|
(942)
|
(991)
|
(1 120)
|
(1 211)
|
(1 629)
|
(1 808)
|
(2 438)
|
(2 534)
|
(2 138)
|
(2 002)
|
(1 560)
|
(1 613)
|
(1 721)
|
(1 839)
|
(1 816)
|
|
| Gross Profit |
1 949
N/A
|
2 121
+9%
|
2 322
+9%
|
2 434
+5%
|
2 615
+7%
|
2 818
+8%
|
3 109
+10%
|
3 467
+12%
|
3 711
+7%
|
4 014
+8%
|
4 248
+6%
|
4 396
+3%
|
4 561
+4%
|
4 706
+3%
|
4 930
+5%
|
5 151
+4%
|
5 475
+6%
|
5 637
+3%
|
5 786
+3%
|
5 943
+3%
|
6 277
+6%
|
6 081
-3%
|
5 996
-1%
|
5 961
-1%
|
7 081
+19%
|
6 507
-8%
|
6 751
+4%
|
7 253
+7%
|
7 377
+2%
|
7 987
+8%
|
10 755
+35%
|
11 735
+9%
|
13 634
+16%
|
13 974
+2%
|
12 089
-13%
|
11 708
-3%
|
10 613
-9%
|
10 757
+1%
|
10 950
+2%
|
11 258
+3%
|
11 301
+0%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 189)
|
(1 322)
|
(1 454)
|
(1 614)
|
(1 791)
|
(1 902)
|
(2 076)
|
(2 230)
|
(2 459)
|
(2 735)
|
(3 006)
|
(3 183)
|
(3 230)
|
(3 274)
|
(3 239)
|
(3 263)
|
(3 396)
|
(3 421)
|
(3 498)
|
(3 588)
|
(3 742)
|
(3 633)
|
(3 856)
|
(3 709)
|
(4 872)
|
(4 077)
|
(3 981)
|
(4 168)
|
(3 801)
|
(3 998)
|
(4 075)
|
(4 261)
|
(4 687)
|
(4 853)
|
(5 009)
|
(5 251)
|
(5 619)
|
(6 047)
|
(6 530)
|
(6 851)
|
(7 068)
|
|
| Selling, General & Administrative |
(330)
|
(355)
|
(380)
|
(426)
|
(519)
|
(575)
|
(653)
|
(719)
|
(839)
|
(969)
|
(1 087)
|
(1 147)
|
(1 178)
|
(1 185)
|
(1 200)
|
(1 236)
|
(1 320)
|
(1 354)
|
(1 412)
|
(1 475)
|
(1 556)
|
(1 517)
|
(1 446)
|
(1 381)
|
(1 835)
|
(1 553)
|
(1 607)
|
(1 629)
|
(1 346)
|
(1 384)
|
(1 451)
|
(1 569)
|
(1 825)
|
(1 869)
|
(1 931)
|
(2 015)
|
(2 116)
|
(2 267)
|
(2 443)
|
(2 554)
|
(2 631)
|
|
| Research & Development |
(860)
|
(967)
|
(1 074)
|
(1 188)
|
(1 271)
|
(1 327)
|
(1 423)
|
(1 511)
|
(1 621)
|
(1 748)
|
(1 917)
|
(2 034)
|
(2 052)
|
(2 090)
|
(2 040)
|
(2 026)
|
(2 075)
|
(2 066)
|
(2 086)
|
(2 113)
|
(2 186)
|
(2 179)
|
(2 535)
|
(2 504)
|
(3 037)
|
(2 679)
|
(2 515)
|
(2 674)
|
(2 735)
|
(2 894)
|
(2 886)
|
(2 867)
|
(2 908)
|
(3 009)
|
(3 089)
|
(3 335)
|
(3 593)
|
(3 850)
|
(4 141)
|
(4 305)
|
(4 439)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
62
|
125
|
176
|
0
|
155
|
141
|
135
|
280
|
281
|
262
|
175
|
46
|
25
|
11
|
99
|
90
|
70
|
53
|
8
|
2
|
|
| Operating Income |
760
N/A
|
799
+5%
|
869
+9%
|
820
-6%
|
823
+0%
|
916
+11%
|
1 033
+13%
|
1 237
+20%
|
1 252
+1%
|
1 280
+2%
|
1 242
-3%
|
1 213
-2%
|
1 331
+10%
|
1 432
+8%
|
1 691
+18%
|
1 888
+12%
|
2 080
+10%
|
2 216
+7%
|
2 288
+3%
|
2 355
+3%
|
2 534
+8%
|
2 447
-3%
|
2 141
-13%
|
2 252
+5%
|
2 210
-2%
|
2 430
+10%
|
2 771
+14%
|
3 085
+11%
|
3 577
+16%
|
3 989
+12%
|
6 680
+67%
|
7 474
+12%
|
8 947
+20%
|
9 121
+2%
|
7 080
-22%
|
6 457
-9%
|
4 994
-23%
|
4 710
-6%
|
4 420
-6%
|
4 407
0%
|
4 233
-4%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(47)
|
(46)
|
(45)
|
(43)
|
(37)
|
(32)
|
(25)
|
(17)
|
(14)
|
(11)
|
(10)
|
(9)
|
(7)
|
(13)
|
(17)
|
(23)
|
(25)
|
(24)
|
(26)
|
(27)
|
14
|
13
|
(105)
|
(89)
|
88
|
(127)
|
217
|
145
|
139
|
331
|
508
|
528
|
329
|
(25)
|
(597)
|
(314)
|
(20)
|
118
|
363
|
140
|
172
|
|
| Non-Reccuring Items |
0
|
0
|
(11)
|
(11)
|
(33)
|
(34)
|
(40)
|
(40)
|
(19)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(28)
|
(225)
|
(225)
|
(255)
|
(283)
|
(86)
|
(186)
|
(186)
|
|
| Total Other Income |
(0)
|
0
|
1
|
3
|
8
|
7
|
8
|
8
|
6
|
10
|
11
|
11
|
6
|
13
|
(9)
|
(0)
|
24
|
39
|
99
|
104
|
5
|
54
|
47
|
53
|
131
|
248
|
259
|
245
|
95
|
74
|
41
|
45
|
50
|
67
|
86
|
120
|
140
|
111
|
79
|
16
|
(20)
|
|
| Pre-Tax Income |
713
N/A
|
753
+5%
|
814
+8%
|
770
-5%
|
761
-1%
|
857
+13%
|
976
+14%
|
1 188
+22%
|
1 225
+3%
|
1 279
+4%
|
1 243
-3%
|
1 216
-2%
|
1 330
+9%
|
1 432
+8%
|
1 666
+16%
|
1 865
+12%
|
2 079
+11%
|
2 232
+7%
|
2 362
+6%
|
2 432
+3%
|
2 554
+5%
|
2 514
-2%
|
2 083
-17%
|
2 216
+6%
|
2 429
+10%
|
2 552
+5%
|
3 246
+27%
|
3 476
+7%
|
3 810
+10%
|
4 395
+15%
|
7 229
+64%
|
8 047
+11%
|
9 326
+16%
|
9 134
-2%
|
6 344
-31%
|
6 038
-5%
|
4 859
-20%
|
4 656
-4%
|
4 775
+3%
|
4 376
-8%
|
4 199
-4%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(289)
|
(359)
|
(411)
|
(425)
|
(423)
|
(511)
|
(532)
|
(616)
|
(589)
|
(537)
|
(500)
|
(418)
|
(434)
|
(469)
|
(511)
|
(587)
|
(554)
|
(478)
|
(444)
|
(320)
|
(177)
|
(155)
|
(82)
|
(127)
|
(313)
|
(272)
|
(262)
|
(320)
|
(297)
|
(391)
|
(1 023)
|
(1 052)
|
(1 251)
|
(1 200)
|
(658)
|
(667)
|
(520)
|
(473)
|
(476)
|
(385)
|
(246)
|
|
| Income from Continuing Operations |
424
|
394
|
403
|
345
|
338
|
346
|
444
|
571
|
636
|
741
|
743
|
797
|
896
|
963
|
1 155
|
1 278
|
1 525
|
1 754
|
1 917
|
2 112
|
2 376
|
2 360
|
2 001
|
2 088
|
2 116
|
2 279
|
2 984
|
3 156
|
3 513
|
4 004
|
6 205
|
6 996
|
8 075
|
7 934
|
5 687
|
5 370
|
4 338
|
4 183
|
4 299
|
3 991
|
3 954
|
|
| Net Income (Common) |
424
N/A
|
394
-7%
|
403
+2%
|
345
-14%
|
338
-2%
|
346
+2%
|
444
+28%
|
571
+29%
|
636
+11%
|
741
+17%
|
743
+0%
|
797
+7%
|
896
+12%
|
963
+7%
|
1 155
+20%
|
1 278
+11%
|
1 199
-6%
|
1 428
+19%
|
1 591
+11%
|
1 798
+13%
|
2 444
+36%
|
2 428
-1%
|
2 069
-15%
|
2 144
+4%
|
2 116
-1%
|
2 279
+8%
|
2 984
+31%
|
3 156
+6%
|
3 513
+11%
|
4 004
+14%
|
6 205
+55%
|
6 996
+13%
|
8 075
+15%
|
7 934
-2%
|
5 687
-28%
|
5 370
-6%
|
4 338
-19%
|
4 183
-4%
|
4 299
+3%
|
3 991
-7%
|
3 954
-1%
|
|
| EPS (Diluted) |
4.29
N/A
|
3.5
-18%
|
3.56
+2%
|
2.93
-18%
|
2.98
+2%
|
3.01
+1%
|
3.85
+28%
|
4.92
+28%
|
5.52
+12%
|
6.49
+18%
|
6.39
-2%
|
6.84
+7%
|
7.72
+13%
|
8.36
+8%
|
9.96
+19%
|
10.92
+10%
|
10.33
-5%
|
12.42
+20%
|
13.89
+12%
|
15.61
+12%
|
21.25
+36%
|
21.01
-1%
|
18.05
-14%
|
18.77
+4%
|
18.39
-2%
|
19.8
+8%
|
25.3
+28%
|
27.7
+9%
|
30.54
+10%
|
36.23
+19%
|
56
+55%
|
61.41
+10%
|
72.09
+17%
|
70.14
-3%
|
49.88
-29%
|
47.6
-5%
|
38.05
-20%
|
36.69
-4%
|
37.74
+3%
|
35.19
-7%
|
34.77
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
